Jumonji Domain Containing 6 (JMJD6) Peptide
JMJD6
Reactivity: Human
Host: Synthetic
BP, WB, IHC
-
- Target See all JMJD6 products
- JMJD6 (Jumonji Domain Containing 6 (JMJD6))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PTDSR antibody (Catalog #: ARP31807_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- JMJD6 (Jumonji Domain Containing 6 (JMJD6))
- Background
-
PTDSR is required during embryogenesis and differentiation of multiple organs during embryogenesis. PTDSR probably acts as a key regulator of hematopoietic differentiation. PTDSR may not be required for apoptotic cell clearance by macrophages but seems to be necessary for the regulation of macrophage cytokine responses
Alias Symbols: PSR, PTDSR, PTDSR1
Protein Interaction Partner: DOCK1,ELMO1
Protein Size: 372 - Molecular Weight
- 43 kDa
- Gene ID
- 23210
- NCBI Accession
- NM_015167, NP_055982
-
You are here:
